[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Urinary Catheters Market by Product (Indwelling, Intermittent, External), Type (Coated, Uncoated), Application (Urinary Incontinence, Benign Prostate Hyperplasia, General Surgery), Usage (Male, Female), End Users (Hospitals) - Global Forecast to 2025

September 2020 | 160 pages | ID: U49C9130A5AEN
MarketsandMarkets

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
“Increasing number of surgical procedures, high incidence of prostate cancer, and the growing prevalence of urinary incontinence are expected to drive the overall growth of the urinary catheters market.”

The global urinary catheters market size is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period. Market growth can be largely attributed to factors such as the growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario. The emerging Asian countries are also expected to offer strong growth opportunities for players in the market. The untapped market opportunities in emerging markets are also expected to provide growth opportunities for players in the market. On the other hand, the complications associated with catheterization and the availability of alternative treatment options for urinary incontinence may restrict market growth to a certain extent.

“The hospital segment is expected to dominate the market during the forecast period.”

Based on end-users, the global urinary catheters market is segmented into hospitals, long-term care facilities, and other end users. Hospitals accounted for the largest share of the urinary catheters market in 2019. The large share of this end-user segment can be attributed to the large volume of patients visiting hospitals due to the rising prevalence of ailments requiring surgical treatment and the high incidence of chronic diseases such as urinary incontinence, multiple sclerosis, and spina bifida.

“The urinary incontinence application segment will witness the highest growth in the urinary catheters market.”

Based on application, the global urinary catheters market is segmented into urinary incontinence, general surgery, benign prostatic hyperplasia, and other applications. The urinary incontinence segment accounted for the largest share of the urinary catheters market in 2019. This segment is also expected to witness the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to the increasing incidence of urinary incontinence, the growing geriatric population, and the rising incidence of obesity.

“North America will dominate the market during the forecast period.”

Geographically, the urinary catheters market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the urinary catheters market. The large share of this region can be attributed factors such as the high prevalence of diseases, growing geriatric population, the availability of advanced interventional products (including urinary catheters), and increasing surgical procedures performed in the region are driving market growth in North America.

The primary interviews conducted for this report can be categorized as follows:
  • By Company Type - Tier 1: 36%, Tier 2: 45%, and Tier 3: 19%
  • By Designation - C-level: 33%, D-level: 40%, and Others: 27%
  • By Region - North America: 36%, Europe: 28%, Asia Pacific: 19%, and Rest of the World: 17%
List of Companies Profiled in the Report
  • B. Braun Melsungen AG (Germany)
  • Boston Scientific Corporation (US)
  • Coloplast Ltd. (Denmark)
  • ConvaTec Inc. (UK)
  • Becton, Dickinson and Company (US)
  • Cardinal Health (US)
  • Teleflex Incorporated (US)
  • Wellspect HealthCare (US)
  • Cook Medical (US)
  • Asid Bonz GmbH (Germany)
  • Degania Silicone Ltd. (Israel)
  • Bactiguard (Sweden)
  • Medical Technologies of Georgia (US)
  • ROCAMED (Monaco)
  • Well Lead Medical Co., Ltd. (China)
  • Go Medical Industries Pty Ltd. (Australia)
  • Cure Medical, LLC
  • Amsino International, Inc. (US)
  • Urocare Products, Inc. (US)
  • J and M Urinary Catheters LLC. (US)
  • CompactCath (US)
  • Hunter Urology (England)
  • MANFRED SAUER GMBH (Germany)
  • Ribbel International Limited (India).
Research Coverage:

This report provides a detailed picture of the global urinary catheters market. It aims at estimating the size and future growth potential of the market across different segments, such as product, type, usage, application, end user, and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total urinary catheters market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on urinary catheters offered by the top 25 players in the urinary catheters market. The report analyses the urinary catheters market by product, type, usage, application, end user, and region.
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various urinary catheters across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the urinary catheters market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the urinary catheters market.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
FIGURE 1 URINARY CATHETERS MARKET
  1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.2 SECONDARY DATA
  2.2.1 KEY DATA FROM SECONDARY SOURCES
2.3 PRIMARY DATA
  2.3.1 KEY DATA FROM PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.4 MARKET SIZE ESTIMATION
  2.4.1 BOTTOM-UP APPROACH
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  2.4.2 GROWTH FORECAST
2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 5 DATA TRIANGULATION METHODOLOGY
2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

FIGURE 6 URINARY CATHETERS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 7 URINARY CATHETERS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 8 URINARY CATHETERS MARKET, BY USAGE, 2020–2025 (USD MILLION)
FIGURE 9 URINARY CATHETERS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 10 URINARY CATHETERS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
FIGURE 11 GEOGRAPHIC SNAPSHOT OF THE GLOBAL URINARY CATHETERS MARKET

4 PREMIUM INSIGHTS

4.1 URINARY CATHETERS MARKET OVERVIEW
FIGURE 12 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
4.2 ASIA PACIFIC: URINARY CATHETERS MARKET, BY APPLICATION & COUNTRY (2019)
FIGURE 13 URINARY INCONTINENCE APPLICATIONS DOMINATED THE URINARY CATHETERS MARKET IN ASIA PACIFIC IN 2019
4.3 URINARY CATHETERS MARKET, BY END USER, 2019
FIGURE 14 HOSPITALS TO BE THE LARGEST END USERS OF URINARY CATHETERS DURING THE FORECAST PERIOD
4.4 URINARY CATHETERS MARKET: GEOGRAPHIC SNAPSHOT
FIGURE 15 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 URINARY CATHETERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND TRENDS
  5.2.1 DRIVERS
    5.2.1.1 Growing prevalence of urinary incontinence
TABLE 1 GLOBAL PREVALENCE OF URINARY INCONTINENCE
      5.2.1.1.1 Increasing rates of obesity
TABLE 2 PROJECTED GROWTH RATE OF OBESITY IN VARIOUS COUNTRIES
      5.2.1.1.2 Rapidly increasing geriatric population
TABLE 3 GLOBAL OVERVIEW OF THE RISE IN THE AGING POPULATION (MILLION)
    5.2.1.2 High incidence of prostate cancer
TABLE 4 GLOBAL INCIDENCE AND PREVALENCE OF PROSTATE CANCER
    5.2.1.3 Increasing number of surgical procedures
TABLE 5 NUMBER OF SURGICAL PROCEDURES, BY COUNTRY, 2014 VS. 2018
    5.2.1.4 Favorable reimbursement scenario
  5.2.2 RESTRAINTS
    5.2.2.1 Complications associated with catheterization and the availability of alternatives
  5.2.3 OPPORTUNITIES
    5.2.3.1 Emerging economies
  5.2.4 TRENDS
    5.2.4.1 Growing preference for single-use catheters and self-catheterization
  5.2.5 COVID IMPACT
5.3 PRICING ANALYSIS
TABLE 6 PRICE OF URINARY CATHETERS (USD)
5.4 VALUE CHAIN ANALYSIS
FIGURE 17 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE
5.5 SUPPLY CHAIN ANALYSIS
FIGURE 18 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.6 ECOSYSTEM ANALYSIS OF THE UROLOGY DEVICES MARKET
FIGURE 19 ECOSYSTEM ANALYSIS OF THE UROLOGY DEVICES MARKET

6 URINARY CATHETERS MARKET, BY PRODUCT

6.1 INTRODUCTION
TABLE 7 URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 8 URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (MILLION UNITS)
6.2 INDWELLING CATHETERS
  6.2.1 INDWELLING CATHETERS TO DOMINATE THE URINARY CATHETERS MARKET DURING THE FORECAST PERIOD
TABLE 9 INDICATIONS FOR SUPRAPUBIC AND URETHRAL CATHETERIZATION
TABLE 10 INDWELLING URINARY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 11 INDWELLING URINARY CATHETERS MARKET, BY REGION, 2018–2025 (MILLION UNITS)
6.3 INTERMITTENT CATHETERS
  6.3.1 INTERMITTENT CATHETERS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD
TABLE 12 INTERMITTENT URINARY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 13 INTERMITTENT URINARY CATHETERS MARKET, BY REGION, 2018–2025 (MILLION UNITS)
6.4 EXTERNAL CATHETERS
  6.4.1 ADVANTAGES SUCH AS MINIMIZED RISK OF DAMAGE TO THE URETHRA TO DRIVE THE MARKET FOR EXTERNAL CATHETERS
TABLE 14 EXTERNAL URINARY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 15 EXTERNAL URINARY CATHETERS MARKET, BY REGION, 2018–2025 (MILLION UNITS)

7 URINARY CATHETERS MARKET, BY TYPE

7.1 INTRODUCTION
TABLE 16 URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
7.2 COATED CATHETERS
  7.2.1 COATED CATHETERS ARE THE LARGEST AND FASTEST-GROWING SEGMENT IN THE URINARY CATHETERS MARKET
TABLE 17 COATED URINARY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
7.3 UNCOATED CATHETERS
  7.3.1 AFFORDABLE PRICE AND EASY AVAILABILITY TO DRIVE THE MARKET FOR UNCOATED CATHETERS
TABLE 18 ADVANTAGES AND DISADVANTAGES OF COMMONLY USED URINARY CATHETER MATERIALS
TABLE 19 UNCOATED URINARY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)

8 URINARY CATHETERS MARKET, BY USAGE

8.1 INTRODUCTION
TABLE 20 URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
8.2 MALE URINARY CATHETERS
  8.2.1 HIGH INCIDENCE OF PROSTATE CANCER TO DRIVE THE MARKET FOR MALE URINARY CATHETERS
TABLE 21 MALE URINARY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
8.3 FEMALE URINARY CATHETERS
  8.3.1 HIGH PREVALENCE OF URINARY INCONTINENCE TO DRIVE THE MARKET FOR FEMALE URINARY CATHETERS
TABLE 22 FEMALE URINARY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)

9 URINARY CATHETERS MARKET, BY APPLICATION

9.1 INTRODUCTION
TABLE 23 URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
9.2 URINARY INCONTINENCE
  9.2.1 URINARY INCONTINENCE APPLICATION SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
TABLE 24 URINARY CATHETERS MARKET FOR URINARY INCONTINENCE APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
9.3 GENERAL SURGERY
  9.3.1 INCREASING NUMBER OF SURGERIES TO DRIVE MARKET GROWTH
TABLE 25 URINARY CATHETERS MARKET FOR GENERAL SURGERY APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
9.4 BENIGN PROSTATIC HYPERPLASIA
  9.4.1 GROWING GLOBAL PREVALENCE OF BENIGN PROSTATIC HYPERPLASIA TO DRIVE THE DEMAND FOR URINARY CATHETERS
TABLE 26 URINARY CATHETERS MARKET FOR BENIGN PROSTATIC HYPERPLASIA APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)
9.5 OTHER APPLICATIONS
TABLE 27 URINARY CATHETERS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018–2025 (USD MILLION)

10 URINARY CATHETERS MARKET, BY END USER

10.1 INTRODUCTION
TABLE 28 URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2 HOSPITALS
  10.2.1 HIGH PATIENT INFLUX AND PROCEDURAL VOLUMES MAKE HOSPITALS THE LARGEST END USERS OF URINARY CATHETERS
TABLE 29 URINARY CATHETERS MARKET FOR HOSPITALS, BY REGION, 2018–2025 (USD MILLION)
10.3 LONG-TERM CARE FACILITIES
  10.3.1 GROWING DEMAND FOR LONG-TERM CARE SUPPORTS THE GROWTH OF THIS END-USER SEGMENT
TABLE 30 URINARY CATHETERS MARKET FOR LONG-TERM CARE FACILITIES, BY REGION, 2018–2025 (USD MILLION)
10.4 OTHER END USERS
TABLE 31 URINARY CATHETERS MARKET FOR OTHER END USERS, BY REGION, 2018–2025 (USD MILLION)

11 URINARY CATHETERS MARKET, BY REGION

11.1 INTRODUCTION
TABLE 32 URINARY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
11.2 NORTH AMERICA
FIGURE 20 NORTH AMERICA: URINARY CATHETERS MARKET SNAPSHOT
TABLE 33 NORTH AMERICA: URINARY CATHETERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 34 NORTH AMERICA: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 35 NORTH AMERICA: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 36 NORTH AMERICA: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 37 NORTH AMERICA: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 38 NORTH AMERICA: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.2.1 US
    11.2.1.1 The US dominates the North American market
TABLE 39 US: KEY MACROINDICATORS
TABLE 40 US: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 41 US: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 42 US: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 43 US: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 44 US: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.2.2 CANADA
    11.2.2.1 Rising prevalence of target diseases to positively impact the market in Canada
TABLE 45 CANADA: KEY MACROINDICATORS
TABLE 46 CANADA: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 47 CANADA: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 48 CANADA: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 49 CANADA: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 50 CANADA: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3 EUROPE
TABLE 51 EUROPE: URINARY CATHETERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 52 EUROPE: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 53 EUROPE: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 54 EUROPE: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 55 EUROPE: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 56 EUROPE: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.3.1 GERMANY
    11.3.1.1 Germany holds the largest share of the urinary catheters market in Europe
TABLE 57 GERMANY: KEY MACROINDICATORS
TABLE 58 GERMANY: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 59 GERMANY: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 60 GERMANY: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 61 GERMANY: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 62 GERMANY: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.3.2 UK
    11.3.2.1 Large number of road accidents to drive the market for urinary catheters in the country
TABLE 63 UK: KEY MACROINDICATORS
TABLE 64 UK: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 65 UK: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 66 UK: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 67 UK: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 68 UK: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.3.3 FRANCE
    11.3.3.1 Favorable government initiatives have supported market growth in France
TABLE 69 FRANCE: KEY MACROINDICATORS
TABLE 70 FRANCE: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 71 FRANCE: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 72 FRANCE: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 73 FRANCE: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 74 FRANCE: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.3.4 ITALY
    11.3.4.1 Increasing healthcare expenditure and investments are driving the market in Italy
TABLE 75 ITALY: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 76 ITALY: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 77 ITALY: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 78 ITALY: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 79 ITALY: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.3.5 SPAIN
    11.3.5.1 Rising geriatric population will aid the market growth
TABLE 80 SPAIN: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 81 SPAIN: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 82 SPAIN: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 83 SPAIN: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 84 SPAIN: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.3.6 REST OF EUROPE (ROE)
TABLE 85 ROE: CANCER CASES AND PROSTATE CANCER (%), BY COUNTRY, 2018
TABLE 86 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2006 VS. 2016 (% OF GDP)
TABLE 87 ROE: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 88 ROE: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 89 ROE: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 90 ROE: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 91 ROE: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4 ASIA PACIFIC
FIGURE 21 ASIA PACIFIC: URINARY CATHETERS MARKET SNAPSHOT
TABLE 92 APAC: URINARY CATHETERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)
TABLE 93 APAC: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 94 APAC: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 95 APAC: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 96 APAC: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 97 APAC: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.4.1 JAPAN
    11.4.1.1 Japan dominates the Asia Pacific market
TABLE 98 JAPAN: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 99 JAPAN: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 100 JAPAN: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 101 JAPAN: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 102 JAPAN: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.4.2 CHINA
    11.4.2.1 Improvements in healthcare infrastructure will favor market growth in China
TABLE 103 CHINA: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 104 CHINA: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 105 CHINA: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 106 CHINA: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 107 CHINA: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.4.3 INDIA
    11.4.3.1 High incidence of target medical conditions to drive the market for urinary catheters in the country
TABLE 108 INDIA: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 109 INDIA: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 110 INDIA: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 111 INDIA: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 112 INDIA: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
  11.4.4 REST OF ASIA PACIFIC
TABLE 113 ROAPAC: CANCER CASES AND PROSTATE CANCER (%), BY COUNTRY, 2018
TABLE 114 ROAPAC: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 115 ROAPAC: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 116 ROAPAC: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 117 ROAPAC: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 118 ROAPAC: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)
11.5 ROW
TABLE 119 ROW: NEW CANCER CASES AND PROSTATE CANCER (%), BY COUNTRY, 2018
TABLE 120 ROW: URINARY CATHETERS MARKET, BY REGION, 2018–2025 (USD MILLION)
TABLE 121 ROW: URINARY CATHETERS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)
TABLE 122 ROW: URINARY CATHETERS MARKET, BY TYPE, 2018–2025 (USD MILLION)
TABLE 123 ROW: URINARY CATHETERS MARKET, BY USAGE, 2018–2025 (USD MILLION)
TABLE 124 ROW: URINARY CATHETERS MARKET, BY APPLICATION, 2018–2025 (USD MILLION)
TABLE 125 ROW: URINARY CATHETERS MARKET, BY END USER, 2018–2025 (USD MILLION)

12 COMPETITIVE LANDSCAPE

12.1 OVERVIEW
FIGURE 22 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2020
FIGURE 23 MARKET EVOLUTION FRAMEWORK
12.2 COMPETITIVE SITUATIONS AND TRENDS
  12.2.1 PARTNERSHIPS & AGREEMENTS
  12.2.2 PRODUCT LAUNCHES & APPROVALS
  12.2.3 EXPANSIONS
  12.2.4 ACQUISITIONS

13 COMPANY EVALUATION MATRIX AND COMPANY PROFILES

13.1 COMPANY EVALUATION MATRIX DEFINITIONS AND METHODOLOGY
  13.1.1 MARKET SHARE ANALYSIS, 2019
FIGURE 24 URINARY CATHETERS MARKET, BY KEY PLAYER, 2019
13.2 COMPANY EVALUATION MATRIX
  13.2.1 STARS
  13.2.2 EMERGING LEADERS
  13.2.3 PERVASIVE PLAYERS
  13.2.4 PARTICIPANTS
FIGURE 25 MNM VENDOR DIVE COMPARISON MATRIX: URINARY CATHETERS MARKET
13.3 COMPETITIVE LEADERSHIP MAPPING (START-UPS)
  13.3.1 PROGRESSIVE COMPANIES
  13.3.2 STARTING BLOCKS
  13.3.3 RESPONSIVE COMPANIES
  13.3.4 DYNAMIC COMPANIES
FIGURE 26 MNM VENDOR DIVE COMPARISON MATRIX FOR START-UPS: URINARY CATHETERS MARKET
13.4 COMPANY PROFILES
(Business Overview, Products Offered, Recent Developments, MnM View)*
  13.4.1 COLOPLAST A/S
FIGURE 27 COLOPLAST A/S: COMPANY SNAPSHOT
  13.4.2 BECTON, DICKINSON AND COMPANY (BD)
FIGURE 28 BECTON, DICKINSON AND COMPANY (BD): COMPANY SNAPSHOT
  13.4.3 CONVATEC GROUP PLC
FIGURE 29 CONVATEC GROUP PLC: COMPANY SNAPSHOT
  13.4.4 CARDINAL HEALTH
FIGURE 30 CARDINAL HEALTH: COMPANY SNAPSHOT
  13.4.5 B. BRAUN MELSUNGEN AG
FIGURE 31 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  13.4.6 BOSTON SCIENTIFIC CORPORATION
FIGURE 32 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  13.4.7 ASID BONZ GMBH
  13.4.8 BACTIGUARD
FIGURE 33 BACTIGUARD: COMPANY SNAPSHOT
  13.4.9 COOK MEDICAL
  13.4.10 CURE MEDICAL
  13.4.11 GO MEDICAL INDUSTRIES PTY LTD.
  13.4.12 HOLLISTER INCORPORATED
  13.4.13 TELEFLEX INCORPORATED
FIGURE 34 TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  13.4.14 WELLSPECT HEALTHCARE (A SUBSIDIARY OF DENTSPLY SIRONA INC.)
FIGURE 35 DENTSPLY SIRONA: COMPANY SNAPSHOT
13.5 OTHER COMPANIES
  13.5.1 AMSINO INTERNATIONAL, INC.
  13.5.2 COMPACTCATH
  13.5.3 DEGANIA SILICONE LTD. (A PART OF Q LIFE SCIENCES)
  13.5.4 HUNTER UROLOGY
  13.5.5 J AND M URINARY CATHETERS LLC
  13.5.6 MANFRED SAUER GMBH
  13.5.7 MEDICAL TECHNOLOGIES OF GEORGIA
  13.5.8 RIBBEL INTERNATIONAL LIMITED
  13.5.9 ROCAMED
  13.5.10 UROCARE PRODUCTS, INC.
  13.5.11 WELL LEAD MEDICAL CO., LTD.
*Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

14 APPENDIX

14.1 DISCUSSION GUIDE
14.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 AVAILABLE CUSTOMIZATIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS


More Publications